Registry collecting information on preeclampsia and related pregnancy blood pressure disorders
Collects medical information from women with preeclampsia and comparison women without it.
Key facts
- Who runs it
- Preeclampsia Foundation
- Where
- Melbourne, United StatesSee the site
- Trial code
- Registry title
- The Preeclampsia Registry
- Status
- Recruiting
- People taking part
- 20,000 people, planned
- Started
- 1 Sept 2013
- Expected to end
- May 2040
- Type of study
- Observational
- Record updated
- 22 April 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry collects health information from women who had preeclampsia or a related high blood pressure problem of pregnancy, their relatives, and women who never had it to act as controls.
- Age
- From 13 years.
- Sex
- Women and men. Women who had the condition or serve as controls; female or male relatives of affected women.
- Disease stage
- Preeclampsia or a related hypertensive disorder of pregnancy, such as eclampsia or HELLP syndrome, diagnosed by a doctor.
Main reasons for not taking part
- People unable to provide consent
- Prisoners
- People unable to speak English
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Women who were medically diagnosed with preeclampsia or a related hypertensive disorder of pregnancy (HDP) such as eclampsia or HELLP syndrome
- Female or Male relatives of affected women
- Women who have never had preeclampsia or hypertensive disorders of pregnancy, but who would like to serve as "controls" in research studies of preeclampsia
- An authorized representative may complete the questionnaire and provide consent for a woman who had preeclampsia, but has died or is disabled as a result
Who cannot take part
- Those unable to provide consent
- Prisoners
- Individuals unable to speak English
Where in United States
- Preeclampsia FoundationMelbourne, United StatesContact: VeeAnn ArgyleTaking people
About the trial
What the trial wants to find out
The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who have not had preeclampsia to serve as controls. Information from participants will be used for medical research to try to understand why preeclampsia occurs, how to predict it better, and to develop experimental clinical trials of new treatments. The Registry will consist of a web-based survey and mechanism for collecting and reviewing medical records. This data will be utilized for immediate investigator-driven cross-sectional research projects (after proposal review by the Registry's scientific advisory board and as directed by the PI). Participants may also choose to be contacted regarding possible participation in future studies, about providing a biospecimen, as well as investigator-driven clinical trials. The Registry is anticipated to exist long-term and to serve as a foundation of participants from which to draw for studies of preeclampsia, anticipated to evolve as our scientific understanding of preeclampsia evolves.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Preeclampsia Registry
- Plain-language title
- Registry collecting information on preeclampsia and related pregnancy blood pressure disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 22 April 2024